Pramipexole for depression and motor symptoms in Parkinson's disease: can we kill two birds with one stone?

The Lancet Neurology

Volumn 9, Issue 6, 2010, Pages 556-557

  Fernandez, Hubert H ^a   Merello, Marcelo ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b FLENI   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; DESIPRAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; NORTRIPTYLINE; PAROXETINE; PLACEBO; PRAMIPEXOLE; ROPINIROLE;

ANHEDONIA; BECK DEPRESSION INVENTORY; CLINICAL TRIAL; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFICACY; DRUG SAFETY; DYSKINESIA; HUMAN; LETTER; LIBIDO DISORDER; MOTOR DYSFUNCTION; NAUSEA; OUTCOME ASSESSMENT; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOMOTOR RETARDATION; SLEEP DISORDER; SOMNOLENCE; TREATMENT DURATION; TREATMENT OUTCOME; UNIFIED PARKINSON DISEASE RATING SCALE; WEIGHT CHANGE;

ANTIDEPRESSIVE AGENTS; ANTIPARKINSON AGENTS; BENZOTHIAZOLES; DEPRESSIVE DISORDER; DOPAMINE AGONISTS; DYSKINESIAS; HUMANS; PARKINSON DISEASE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77952319461     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(10)70114-9     Document Type: Letter

References (9)

1. Rodriguez-Oroz M.C., Jahanshahi M., Krack P., et al. Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. Lancet Neurol 8 (2009) 1128-1139
2. Barone P., Poewe W., Albrecht S., et al. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol (2010) 10.1016/S1474-4422(10)70106-X published online May 10.
3. Starkstein S.E., Merello M., Jorge R., et al. A validation study of depressive syndromes in Parkinson's disease. Mov Disord 23 (2008) 538-546
4. Marsh L., McDonald W.M., Cummings J., Ravina B., and NINDS/NIMH Work Group on Depression and Parkinson's Disease. Provisional diagnostic criteria for depression in Parkinson's disease: report of an NINDS/NIMH Work Group. Mov Disord 21 (2006) 148-158
5. Okun M.S., and Fernandez H.H. Will tricyclic antidepressants make a comeback for depressed Parkinson disease patients?. Neurology 72 (2009) 868-869
6. Menza M., Dobkin R.D., Marin H., et al. A controlled trial of antidepressants in patients with Parkinson disease and depression. Neurology 72 (2009) 886-892
7. Devos D., Dujardin K., Poirot I., et al. Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study. Mov Disord 23 (2008) 850-857
8. Pahwa R., Stacy M.A., Factor S.A., et al. Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease. Neurology 68 (2007) 1108-1115
9. Schrag A., Barone P., Brown R.G., et al. Depression rating scales in Parkinson's disease: critique and recommendations. Mov Disord 22 (2007) 1077-1092